Skeletal Disease Drug Development Pipeline Review, 2017; New Report Launched
This report provides an overview of the skeletal disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for osteoporosis, post-menopausal osteoporosis and osteoarthritis (OA).
View full press release